Evaluating  	Evaluating  	 VBG	O
iatrogenic  	iatrogenic  	 JJ	B-NP
prescribing 	prescribing 	 NN	I-NP
:  	:  	 :	O
development  	development  	 NN	O
of  	of  	 IN	O
an  	an  	 DT	O
oncology-focused  	oncology-focused  	 JJ	B-NP
trigger  	trigger  	 NN	I-NP
tool  	tool  	 NN	I-NP
Drug-related  	Drug-related  	 JJ	O
iatrogenic  	iatrogenic  	 JJ	B-NP
effects  	effects  	 NNS	I-NP
are  	are  	 VBP	O
common  	common  	 JJ	O
in  	in  	 IN	O
oncology  	oncology  	 NN	B-NP
because  	because  	 IN	O
chemotherapy  	chemotherapy  	 NN	O
is  	is  	 VBZ	O
toxic 	toxic 	 JJ	B-NP
.  	.  	 .	O
The  	The  	 DT	O
evaluation  	evaluation  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
application  	application  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
guidelines  	guidelines  	 NNS	O
may  	may  	 MD	O
be  	be  	 VB	O
a  	a  	 DT	O
way  	way  	 NN	O
to  	to  	 TO	O
understand  	understand  	 VB	O
the  	the  	 DT	O
occurrence  	occurrence  	 NN	O
of  	of  	 IN	O
adverse  	adverse  	 JJ	B-NP
drug-related  	drug-related  	 JJ	I-NP
event  	event  	 NN	I-NP
( 	( 	 -LRB-	O
ADE 	ADE 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
There  	There  	 EX	O
is  	is  	 VBZ	O
no  	no  	 DT	O
specific  	specific  	 JJ	O
method  	method  	 NN	O
for  	for  	 IN	O
identifying  	identifying  	 VBG	B-NP
ADEs  	ADEs  	 JJ	I-NP
and  	and  	 CC	O
measuring  	measuring  	 VBG	B-NP
harm  	harm  	 NN	I-NP
to  	to  	 TO	O
patients  	patients  	 NNS	O
in  	in  	 IN	O
oncology 	oncology 	 NN	B-NP
.  	.  	 .	O
Our  	Our  	 PRP$	O
objective  	objective  	 NN	B-NP
was  	was  	 VBD	O
to  	to  	 TO	O
develop  	develop  	 VB	O
and  	and  	 CC	O
test  	test  	 VB	O
an  	an  	 DT	O
Oncology  	Oncology  	 NNP	B-NP
Trigger  	Trigger  	 NNP	I-NP
Tool  	Tool  	 NNP	I-NP
( 	( 	 -LRB-	O
OTT 	OTT 	 NNP	B-NP
)  	)  	 -RRB-	O
for  	for  	 IN	O
ADEs  	ADEs  	 JJ	B-NP
and  	and  	 CC	O
to  	to  	 TO	O
describe  	describe  	 VB	O
ADE  	ADE  	 JJ	B-NP
characteristics  	characteristics  	 NNS	I-NP
and  	and  	 CC	O
incidence 	incidence 	 NN	O
.  	.  	 .	O
A  	A  	 DT	O
clinical  	clinical  	 JJ	B-NP
advisory  	advisory  	 JJ	I-NP
panel  	panel  	 NN	I-NP
identified  	identified  	 VBN	I-NP
situations  	situations  	 NNS	I-NP
at  	at  	 IN	O
high  	high  	 JJ	O
risk  	risk  	 NN	O
of  	of  	 IN	O
ADE  	ADE  	 NNP	B-NP
occurrence  	occurrence  	 NN	I-NP
and  	and  	 CC	O
built  	built  	 VBD	O
22  	22  	 CD	O
triggers  	triggers  	 NN	O
with 	with 	 IN	O
,  	,  	 ,	O
in  	in  	 IN	O
each  	each  	 DT	O
case 	case 	 NN	O
,  	,  	 ,	O
an  	an  	 DT	O
analysis  	analysis  	 NN	B-NP
flowchart  	flowchart  	 NN	I-NP
to  	to  	 TO	O
confirm  	confirm  	 VB	O
or  	or  	 CC	O
refute  	refute  	 JJ	O
occurrence 	occurrence 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
OTT  	OTT  	 NNP	B-NP
was  	was  	 VBD	O
used  	used  	 VBN	O
to  	to  	 TO	O
review  	review  	 VB	O
288  	288  	 CD	O
random  	random  	 JJ	O
admissions  	admissions  	 NNS	O
( 	( 	 -LRB-	O
Oct.  	Oct.  	 NNP	O
2010-Sept.  	2010-Sept.  	 CD	O
2011 	2011 	 CD	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
measure  	measure  	 NN	B-NP
ADE  	ADE  	 NNP	I-NP
incidence  	incidence  	 NN	I-NP
and  	and  	 CC	O
severity  	severity  	 NN	O
( 	( 	 -LRB-	O
CTCAE  	CTCAE  	 NNP	B-NP
4.03  	4.03  	 CD	O
-  	-  	 :	O
Common  	Common  	 NNP	B-NP
Terminology  	Terminology  	 NNP	I-NP
Criteria  	Criteria  	 NNP	I-NP
for  	for  	 IN	I-NP
Adverse  	Adverse  	 JJ	I-NP
Events 	Events 	 NNS	I-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
Tool  	Tool  	 NN	B-NP
feasibility  	feasibility  	 NN	I-NP
( 	( 	 -LRB-	O
time  	time  	 NN	O
required 	required 	 VBN	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
inter-rater  	inter-rater  	 NNP	B-NP
( 	( 	 -LRB-	O
IR 	IR 	 NNP	B-NP
)  	)  	 -RRB-	O
reproducibility  	reproducibility  	 NN	B-NP
and  	and  	 CC	O
positive  	positive  	 JJ	B-NP
predictive  	predictive  	 JJ	I-NP
value  	value  	 NN	I-NP
( 	( 	 -LRB-	O
PPV 	PPV 	 NNP	B-NP
)  	)  	 -RRB-	O
were  	were  	 VBD	O
measured 	measured 	 VBN	O
.  	.  	 .	O
Overall 	Overall 	 RB	O
,  	,  	 ,	O
884  	884  	 CD	O
triggers  	triggers  	 NNS	O
were  	were  	 VBD	O
detected  	detected  	 VBN	O
and  	and  	 CC	O
122  	122  	 CD	O
ADEs 	ADEs 	 NN	B-NP
,  	,  	 ,	O
with  	with  	 IN	O
42.4  	42.4  	 NNP	O
ADEs 	ADEs 	 NNP	B-NP
/ 	/ 	 CD	O
100  	100  	 CD	O
admissions  	admissions  	 NNS	O
or  	or  	 CC	O
46.0  	46.0  	 NNP	O
ADEs 	ADEs 	 NNP	B-NP
/ 	/ 	 CD	O
1000  	1000  	 CD	O
patient-days 	patient-days 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
a  	a  	 DT	O
31.1 	31.1 	 CD	O
%  	%  	 NN	O
rate  	rate  	 NN	O
of  	of  	 IN	O
severe  	severe  	 JJ	O
ADEs 	ADEs 	 NN	B-NP
.  	.  	 .	O
The  	The  	 DT	O
most  	most  	 RBS	O
common  	common  	 JJ	O
ADEs  	ADEs  	 NN	B-NP
were  	were  	 VBD	O
hyperglycaemia  	hyperglycaemia  	 NNS	B-NP
( 	( 	 -LRB-	O
14.5 	14.5 	 CD	O
% 	% 	 NN	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
unplanned  	unplanned  	 JJ	O
drug-related  	drug-related  	 JJ	O
admission  	admission  	 NN	B-NP
within  	within  	 IN	O
30  	30  	 CD	O
days  	days  	 NNS	O
( 	( 	 -LRB-	O
13.7 	13.7 	 CD	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
opiate-induced  	opiate-induced  	 JJ	O
constipation  	constipation  	 NNS	B-NP
( 	( 	 -LRB-	O
12.1 	12.1 	 CD	O
% 	% 	 NN	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Unplanned  	Unplanned  	 JJ	O
drug-related  	drug-related  	 JJ	O
admission  	admission  	 NN	B-NP
was  	was  	 VBD	O
the  	the  	 DT	O
most  	most  	 RBS	O
serious  	serious  	 JJ	O
( 	( 	 -LRB-	O
82.4 	82.4 	 NNP	O
%  	%  	 NN	O
incidence  	incidence  	 NN	O
of  	of  	 IN	O
severe  	severe  	 JJ	O
harm 	harm 	 NN	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Mean  	Mean  	 JJ	B-NP
time  	time  	 NN	I-NP
for  	for  	 IN	I-NP
OTT  	OTT  	 NNP	I-NP
implementation  	implementation  	 NN	I-NP
was  	was  	 VBD	O
21.8  	21.8  	 CD	O
min 	min 	 NNS	B-NP
;  	;  	 :	O
IR  	IR  	 NNP	B-NP
reproducibility  	reproducibility  	 NN	I-NP
was  	was  	 VBD	O
high  	high  	 JJ	O
( 	( 	 -LRB-	O
κ=0.965  	κ=0.965  	 NNP	O
( 	( 	 -LRB-	O
trigger 	trigger 	 NN	O
) 	) 	 -RRB-	O
;  	;  	 :	O
κ=0.935  	κ=0.935  	 CD	O
( 	( 	 -LRB-	O
ADE 	ADE 	 NNP	B-NP
) 	) 	 -RRB-	O
;  	;  	 :	O
κ=0.853  	κ=0.853  	 CD	O
( 	( 	 -LRB-	O
harm 	harm 	 NN	O
) 	) 	 -RRB-	O
) 	) 	 -RRB-	O
;  	;  	 :	O
PPV  	PPV  	 NNP	B-NP
22-trigger  	22-trigger  	 NNP	O
version  	version  	 NN	O
was  	was  	 VBD	O
20.7 	20.7 	 CD	O
% 	% 	 NN	O
.  	.  	 .	O
ADE  	ADE  	 NNP	B-NP
analysis  	analysis  	 NN	I-NP
flowcharts  	flowcharts  	 VBZ	O
coupled  	coupled  	 VBN	O
with  	with  	 IN	O
standardised  	standardised  	 JJ	B-NP
grading  	grading  	 NN	I-NP
of  	of  	 IN	O
harm  	harm  	 NN	O
considerably  	considerably  	 RB	O
reduced  	reduced  	 VBN	B-NP
IR  	IR  	 NNP	I-NP
variability 	variability 	 NN	I-NP
,  	,  	 ,	O
thus  	thus  	 RB	O
providing  	providing  	 VBG	O
a  	a  	 DT	O
robust  	robust  	 JJ	O
oncology-focused  	oncology-focused  	 JJ	B-NP
trigger  	trigger  	 NN	I-NP
tool  	tool  	 NN	I-NP
for  	for  	 IN	O
use  	use  	 NN	O
in  	in  	 IN	O
ADE  	ADE  	 NNP	B-NP
audits  	audits  	 NN	I-NP
and  	and  	 CC	O
hospital  	hospital  	 NN	B-NP
comparisons 	comparisons 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
involvement  	involvement  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
clinical  	clinical  	 JJ	B-NP
advisory  	advisory  	 JJ	I-NP
panel  	panel  	 NN	I-NP
in  	in  	 IN	O
tool  	tool  	 NN	B-NP
development  	development  	 NN	I-NP
should  	should  	 MD	O
help  	help  	 VB	O
drive  	drive  	 NN	B-NP
changes  	changes  	 NNS	I-NP
for  	for  	 IN	I-NP
improving  	improving  	 VBG	I-NP
practice 	practice 	 NN	I-NP
.  	.  	 .	O
Further  	Further  	 JJ	B-NP
research  	research  	 NN	I-NP
on  	on  	 IN	O
the  	the  	 DT	O
OTT  	OTT  	 NNP	B-NP
is  	is  	 VBZ	O
warranted 	warranted 	 VBN	O
.  	.  	 .	O
